STAT

Opinion: Patients vs. paywalls: Is the U.S. ready for open-access publishing?

As U.S. scientific publishing moves toward an open-access model, publishing companies will need to adapt and innovate.

Scientific publishing giant Elsevier recently came under fire after its director of scholarly communications, William Gunn, wrote a controversial tweet in response to a post that “people shouldn’t have to jump through hoops” to access important medical research.

While I disagree entirely with the harsh tone of Gunn’s tweet, the underlying rationale behind his comment should not be overlooked: to manage submissions, peer review, editing, and publication, quality scientific publishing requires infrastructure that costs money.

In this age of fast and free access to published information, many people

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.

Related Books & Audiobooks